Crunch time for heart failure care in England and Wales

Lancet. 2010 Dec 18;376(9758):2041. doi: 10.1016/S0140-6736(10)62280-5.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Angiotensin Receptor Antagonists / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Cardiology
  • Cardiovascular Agents / therapeutic use*
  • England / epidemiology
  • Heart Failure* / diagnosis
  • Heart Failure* / drug therapy
  • Heart Failure* / epidemiology
  • Heart Failure* / etiology
  • Heart Failure* / mortality
  • Humans
  • Interdisciplinary Communication
  • Medical Audit
  • Mineralocorticoid Receptor Antagonists / therapeutic use
  • Referral and Consultation
  • Risk Factors
  • Sodium Potassium Chloride Symporter Inhibitors / therapeutic use
  • Stroke Volume
  • United Kingdom / epidemiology
  • Wales / epidemiology

Substances

  • Adrenergic beta-Antagonists
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Cardiovascular Agents
  • Mineralocorticoid Receptor Antagonists
  • Sodium Potassium Chloride Symporter Inhibitors